Could a simple MRI replace kidney biopsies?

NCT ID NCT06202235

Recruiting now Knowledge-focused Sponsor: Shengjing Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a special MRI technique called MR elastography can detect kidney scarring (fibrosis) in people with early chronic kidney disease. Researchers will scan 200 adults—some with kidney disease and some healthy—and track their kidney function for two years. The goal is to see if this non-invasive method can catch damage early, potentially reducing the need for painful biopsies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetic Resonance Imaging (MRI) with elastography
What this could lead to: If successful, this could lead to a non-invasive way to detect kidney scarring early, helping doctors monitor disease without repeated biopsies.
What could go wrong: This is an early observational study, not a treatment trial. The MRI technique may not prove accurate enough to replace biopsies, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE (CKD)

Contacts and locations

Locations

Shengjing Hospital of China Medical University
RECRUITING

Shenyang, Liaoning, 110004, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.